We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A Comprehensive Review and Androgen Deprivation Therapy and Its Impact on Alzheimer's Disease Risk in Older Men with Prostate Cancer.
- Authors
Singh, Manisha; Agarwal, Vinayak; Pancham, Pranav; Jindal, Divya; Agarwal, Shriya; Rai, Sachchida Nand; Singh, Santosh Kumar; Gupta, Vivek
- Abstract
Prostate cancer (PCa) is one of the most prevalent malignancies affecting males worldwide. Despite reductions in mortality rates due to advances in early identification and treatment methods, PCa remains a major health concern. Recent research has shed light on a possible link between PCa and Alzheimer's disease (AD), which is a significant neurological ailment that affects older males all over the world. Androgen deprivation therapy (ADT), a cornerstone therapeutic method used in conjunction with radiation and palliative care in advanced metastatic PCa cases, is critical for disease management. Evidence reveals a relationship between ADT and cognitive impairment. Hormonal manipulation may cause long-term cognitive problems through processes such as amyloid beta (Aβ) aggregation and neurofibrillary tangles (NFTs). Fluctuations in basal androgen levels can upset the delicate balance of genes that are sensitive to androgen levels, contributing to cognitive impairment. This detailed review dives into the various aspects of PCa aetiology and its relationship with cognitive decline. It investigates the discovery of particular biomarkers, as well as microRNAs (miRNAs), which play important roles in pathogenic progression. The review attempts to identify potential biomarkers associated with ADT-induced cerebral changes, including Aβ oligomer buildup, NFT formation, and tauopathy, which can contribute to early-onset dementia and cognitive impairment. Besides it further aims to provide insights into innovative diagnostic and therapeutic avenues for alleviating PCa and ADT-related cognitive sequelae by unravelling these complicated pathways and molecular mechanisms.
- Subjects
PROSTATE cancer; DISEASE risk factors; ANDROGEN deprivation therapy; PROSTATE cancer patients; OLDER men; ALZHEIMER'S disease
- Publication
Degenerative Neurological & Neuromuscular Disease, 2024, Vol 14, p33
- ISSN
1179-9900
- Publication type
Article
- DOI
10.2147/DNND.S445130